Regeneron Pharmaceuticals, Inc., United States
Disclosure information not submitted.
Structural Analysis of Cancer-Relevant TCR-CD3 and Peptide-MHC Complexes By CryoEM
Tuesday, July 25, 20239:15 AM – 9:30 AM US CST